Rhode Island H7692 aims to control Medicaid prescription drug costs by enhancing transparency and accountability for managed care organizations and.

Rhode Island H7692 seeks to protect Rhode Islanders and the state Medicaid program from high prescription drug costs. It imposes transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs). The bill mandates that PBMs cease activities like spread pricing, where they charge more than the reimbursement amount to pharmacies, and discriminatory treatment of non-affiliated pharmacies. It also requires PBMs to stop utilization management processes that delay or prevent medically necessary care.

Rhode Island H7692 aims to control Medicaid prescription drug costs by enhancing transparency and accountability for managed care organizations and.

Rhode Island H7692 seeks to protect Rhode Islanders and the state Medicaid program from high prescription drug costs. It imposes transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs). The bill mandates that PBMs cease activities like spread pricing, where they charge more than the reimbursement amount to pharmacies, and discriminatory treatment of non-affiliated pharmacies. It also requires PBMs to stop utilization management processes that delay or prevent medically necessary care.